About Halyard Health (NYSE:HYH)
Halyard Health, Inc. operates as a medical technology company that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. Its Medical Devices segment provides a portfolio of products that focuses on respiratory and digestive health, along with surgical and interventional pain management. Its products include post-operative pain management solutions, minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes. This segment sells its products under the ON-Q, COOLIEF, MICROCUFF, MIC-KEY, HOMEPUMP, CORTRAK, and other brand names. The company markets its products directly to hospitals and other healthcare providers, as well as through third-party distribution channels. Halyard Health, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
SymbolNYSE:HYH
CUSIPN/A
Phone678-425-9273
Debt
Debt-to-Equity Ratio0.45%
Current Ratio2.98%
Quick Ratio2.74%
Price-To-Earnings
Trailing P/E Ratio20.67
Forward P/E Ratio49.29
P/E Growth5.61
Sales & Book Value
Annual Sales$611.60 million
Price / Sales3.63
Cash Flow$1.2262 per share
Price / Cash38.59
Book Value$25.95 per share
Price / Book1.82
Profitability
EPS (Most Recent Fiscal Year)$2.35
Net Income$79.30 million
Net Margins5.82%
Return on Equity6.98%
Return on Assets3.82%
Miscellaneous
Employees13,000
Outstanding Shares46,920,000
Halyard Health (NYSE:HYH) Frequently Asked Questions
What is Halyard Health's stock symbol?
Halyard Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "HYH."
How were Halyard Health's earnings last quarter?
Halyard Health (NYSE:HYH) released its quarterly earnings data on Tuesday, February, 27th. The medical instruments supplier reported $0.73 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.50 by $0.23. The medical instruments supplier had revenue of $428.10 million for the quarter, compared to the consensus estimate of $413.94 million. Halyard Health had a return on equity of 6.98% and a net margin of 5.82%. The company's revenue was up 4.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.50 EPS. View Halyard Health's Earnings History.
When is Halyard Health's next earnings date?
What price target have analysts set for HYH?
4 equities research analysts have issued 1-year price objectives for Halyard Health's shares. Their forecasts range from $42.00 to $52.00. On average, they anticipate Halyard Health's stock price to reach $47.00 in the next twelve months. View Analyst Ratings for Halyard Health.
Who are some of Halyard Health's key competitors?
Who are Halyard Health's key executives?
Halyard Health's management team includes the folowing people:
- Mr. Steven E. Voskuil, Sr. VP & CFO (Age 50)
- Mr. John W. Wesley, Sr. VP & Gen. Counsel (Age 59)
- Ms. Rhonda D. Gibby, Sr. VP & Chief HR Officer (Age 50)
- Mr. Joseph F. Woody, CEO & Director (Age 52)
- Mr. Renato Negro, VP, Controller & Chief Accounting Officer
Has Halyard Health been receiving favorable news coverage?
Press coverage about HYH stock has been trending somewhat positive on Saturday, Accern reports. The research group ranks the sentiment of news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Halyard Health earned a news sentiment score of 0.17 on Accern's scale. They also assigned headlines about the medical instruments supplier an impact score of 45.36 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next several days.
How do I buy shares of Halyard Health?
Shares of HYH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Halyard Health's stock price today?
One share of HYH stock can currently be purchased for approximately $47.32.
How big of a company is Halyard Health?
Halyard Health has a market capitalization of $2.25 billion and generates $611.60 million in revenue each year. The medical instruments supplier earns $79.30 million in net income (profit) each year or $2.35 on an earnings per share basis. Halyard Health employs 13,000 workers across the globe.
How can I contact Halyard Health?
Halyard Health's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The medical instruments supplier can be reached via phone at 678-425-9273 or via email at [email protected]
MarketBeat Community Rating for Halyard Health (HYH)
MarketBeat's community ratings are surveys of what our community members think about Halyard Health and other stocks. Vote "Outperform" if you believe HYH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HYH will underperform the S&P 500 over the long term. You may vote once every thirty days.
Halyard Health (NYSE:HYH) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
4 Wall Street analysts have issued ratings and price targets for Halyard Health in the last 12 months. Their average twelve-month price target is $47.00, suggesting that the stock has a possible downside of 0.68%. The high price target for HYH is $52.00 and the low price target for HYH is $42.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 3.00 | 2.75 | 2.75 | 2.60 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $47.00 | $47.00 | $47.00 | $41.6667 |
| Price Target Upside: | 0.68% downside | 0.70% downside | 0.70% downside | 4.02% downside |
Halyard Health (NYSE:HYH) Consensus Price Target History
Halyard Health (NYSE:HYH) Analyst Ratings History
Show:
(Data available from 4/21/2016 forward)
Halyard Health (NYSE:HYH) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Halyard Health (NYSE HYH) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 1.44%
Institutional Ownership Percentage: 91.34%
Halyard Health (NYSE HYH) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 9/4/2015 | Robert E Abernathy | CEO | Buy | 10,000 | $31.06 | $310,600.00 | 80,043 |  |
| 9/1/2015 | Steven E Voskuil | CFO | Buy | 1,000 | $30.00 | $30,000.00 | 28,729 | |
(Data available from 1/1/2013 forward)
Halyard Health (NYSE HYH) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Halyard Health (HYH) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - April 19 at 7:21 PM |
| Halyard Health (HYH) Upgraded by Zacks Investment Research to "Buy"
www.americanbankingnews.com - April 18 at 11:54 PM |
 | Owens & Minor Medical, Inc. -- Moody's downgrades Owens & Minor's CFR to B1; outlook stable
finance.yahoo.com - April 18 at 8:30 AM |
| Halyard Health (HYH) Rating Increased to Strong-Buy at ValuEngine
www.americanbankingnews.com - April 13 at 11:10 PM |
| Stephens Upgrades Halyard Health (HYH) to "Overweight"
www.americanbankingnews.com - April 13 at 6:39 PM |
| Deutsche Bank Increases Halyard Health (HYH) Price Target to $42.00
www.americanbankingnews.com - April 13 at 3:16 PM |
| $153.20 Million in Sales Expected for Halyard Health Inc (HYH) This Quarter
www.americanbankingnews.com - April 12 at 3:54 AM |
| Comparing Halyard Health (HYH) & Coloplast A/S (CLPBY)
www.americanbankingnews.com - April 11 at 9:20 PM |
| -$0.04 EPS Expected for Halyard Health Inc (HYH) This Quarter
www.americanbankingnews.com - April 10 at 9:10 AM |
| 24 Georgia CEOs earned more than 100X their employees' median pay in 2017
finance.yahoo.com - April 9 at 8:40 AM |
| Halyard Health (HYH) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - April 7 at 11:36 PM |
| Halyard Health (HYH) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - April 7 at 7:46 PM |
 | Joe Woody
www.benzinga.com - April 7 at 8:45 AM |
 | Trump meets his match: Stormy Daniels' combative lawyer Michael Avenatti
www.latimes.com - April 7 at 8:45 AM |
| Benzinga's Top Analyst Calls From April 6, 2018
finance.yahoo.com - April 7 at 8:45 AM |
| Halyard Health (HYH) Earns "Hold" Rating from KeyCorp
www.americanbankingnews.com - April 6 at 9:16 PM |
| Halyard Health Has 34% Upside Potential, KeyBanc Says In Upgrade
finance.yahoo.com - April 6 at 5:28 PM |
| Halyard Health (HYH) Rating Increased to Overweight at KeyCorp
www.americanbankingnews.com - April 5 at 9:36 PM |
| Halyard Health (HYH) Downgraded by TheStreet
www.americanbankingnews.com - April 2 at 3:16 PM |
| Halyard Health, Inc. Appoints Sarker as Senior Vice President, International
finance.yahoo.com - April 2 at 8:58 AM |
| Brokerages Anticipate Halyard Health Inc (HYH) Will Post Quarterly Sales of $153.20 Million
www.americanbankingnews.com - March 26 at 7:02 AM |
| Halyard Health Inc (HYH) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - March 25 at 7:26 PM |
| Zacks Investment Research Downgrades Halyard Health (HYH) to Hold
www.americanbankingnews.com - March 24 at 1:36 PM |
| Brokerages Expect Halyard Health Inc (HYH) to Announce -$0.04 EPS
www.americanbankingnews.com - March 24 at 9:50 AM |
| Brokerages Expect Halyard Health Inc (HYH) Will Announce Quarterly Sales of $153.20 Million
www.americanbankingnews.com - March 9 at 2:23 PM |
| Halyard Health Upgrades ON-Q* TRAC Patient Engagement Platform for Physicians and Hospitals
finance.yahoo.com - March 9 at 8:39 AM |
| Halyard Health, Inc. to Present at the Barclays Global Healthcare Conference
finance.yahoo.com - March 7 at 8:38 AM |
| Cove Street Capital LLC Has $16.60 Million Holdings in Halyard Health Inc (HYH)
www.americanbankingnews.com - March 5 at 4:07 PM |
| Swiss National Bank Buys 1,800 Shares of Halyard Health Inc (HYH)
www.americanbankingnews.com - March 5 at 4:03 PM |
| KeyCorp Weighs in on Halyard Health Inc's Q1 2018 Earnings (HYH)
www.americanbankingnews.com - March 5 at 2:08 AM |
| State of Wisconsin Investment Board Acquires Shares of 50,000 Halyard Health Inc (HYH)
www.americanbankingnews.com - March 4 at 9:32 AM |
| Halyard Health (HYH) Raised to Strong-Buy at Zacks Investment Research
www.americanbankingnews.com - March 2 at 11:56 PM |
| Channing Capital Management LLC Acquires New Holdings in Halyard Health Inc (HYH)
www.americanbankingnews.com - March 2 at 5:32 AM |
| Analysts’ Ratings for Integer Holdings Corporation and Peers
finance.yahoo.com - March 1 at 8:27 AM |
| Exploring the Business Segments of Integer Holdings Corporation
finance.yahoo.com - March 1 at 8:27 AM |
| The Geographic Segments of Integer Holdings Corporation
finance.yahoo.com - March 1 at 8:27 AM |
| Halyard Health (HYH) Upgraded at ValuEngine
www.americanbankingnews.com - February 28 at 10:16 PM |
| Halyard Health Inc (HYH) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - February 28 at 9:28 PM |
 | Halyard Health, Inc. to Present at the Raymond James 39th Annual Institutional ...
www.prnewswire.com - February 28 at 5:51 PM |
| Systematic Financial Management LP Decreases Stake in Halyard Health Inc (HYH)
www.americanbankingnews.com - February 28 at 5:46 PM |
| Halyard Health, Inc. to Present at the Raymond James 39th Annual Institutional Investors Conference
finance.yahoo.com - February 28 at 8:31 AM |
| Halyard tops 4Q profit forecasts
finance.yahoo.com - February 27 at 5:44 PM |
| Halyard Health (HYH) Releases Quarterly Earnings Results, Beats Estimates By $0.23 EPS
www.americanbankingnews.com - February 27 at 11:36 AM |
 | Halyard Health, Inc. Announces Fourth Quarter and Full-Year 2017 Results
www.bizjournals.com - February 27 at 8:35 AM |
| Is Halyard Health Inc (NYSE:HYH) A Sell At Its Current PE Ratio?
finance.yahoo.com - February 27 at 8:35 AM |
| Spark Investment Management LLC Has $7.89 Million Position in Halyard Health Inc (HYH)
www.americanbankingnews.com - February 26 at 3:02 PM |
| Aperio Group LLC Has $1.57 Million Holdings in Halyard Health Inc (HYH)
www.americanbankingnews.com - February 24 at 5:00 AM |
| Halyard Health (HYH) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - February 19 at 4:30 AM |
| Analysts Anticipate Halyard Health Inc (HYH) to Post $0.49 Earnings Per Share
www.americanbankingnews.com - February 18 at 1:34 PM |
| Halyard Health, Inc. To Webcast Conference Call Discussing Fourth Quarter and Full-Year 2017 Financial Results
finance.yahoo.com - February 13 at 9:52 AM |
Halyard Health (NYSE:HYH) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Halyard Health (NYSE:HYH) Income Statement, Balance Sheet and Cash Flow Statement
Halyard Health (NYSE HYH) Stock Chart for Saturday, April, 21, 2018
Loading chart…
